Clinical Trials Logo

Multiple System Atrophy (MSA) clinical trials

View clinical trials related to Multiple System Atrophy (MSA).

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT05086094 No longer available - Clinical trials for Multiple System Atrophy (MSA)

Expanded Access Protocol of Verdiperstat in Patients With Multiple System Atrophy (MSA)

Start date: n/a
Phase:
Study type: Expanded Access

The purpose of this expanded access program is to provide access to the investigational drug verdiperstat in patients with Multiple System Atrophy (MSA). Expanded access allows patients with a serious or a life-threatening disease or condition access to an investigational drug when no satisfactory approved treatment options are available.